{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:35:42Z","timestamp":1765294542341,"version":"3.44.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"16-17","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003010","name":"Ege \u00c3\u009cniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.clinbiochem.2012.06.024","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T14:55:15Z","timestamp":1340808915000},"page":"1325-1330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?"],"prefix":"10.1016","volume":"45","author":[{"given":"\u00d6zben O.","family":"I\u015f\u0131klar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcu","family":"Barutcuo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ceyda","family":"Kabaro\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I\u015f\u0131l","family":"Mutaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilek","family":"\u00d6zmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oya","family":"Bay\u0131nd\u0131r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Zoghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice","family":"Uluer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinbiochem.2012.06.024_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V90.1.1","article-title":"Homocysteine and thrombotic disease","volume":"90","author":"D'Angelo","year":"1997","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.clinbiochem.2012.06.024_bb0010","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1001\/archinte.163.16.1933","article-title":"Association of elevated homocysteine levels with a higher risk of recurrent coronary events and mortality in patients with acute myocardial infarction","volume":"163","author":"Matetzky","year":"2003","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.clinbiochem.2012.06.024_bb0015","doi-asserted-by":"crossref","first-page":"H2649","DOI":"10.1152\/ajpheart.00548.2005","article-title":"Mechanisms of homocysteine-induced oxidative stress","volume":"289","author":"Tyagi","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8","key":"10.1016\/j.clinbiochem.2012.06.024_bb0020","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/01.CIR.0000085067.55901.89","article-title":"Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine","volume":"108","author":"St\u00fchlinger","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1389200052997393","article-title":"Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction","volume":"6","author":"St\u00fchlinger","year":"2005","journal-title":"Curr Drug Metab"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.06.024_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.RES.87.2.99","article-title":"LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases","volume":"87","author":"B\u00f6ger","year":"2000","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.06.024_bb0035","doi-asserted-by":"crossref","first-page":"H816","DOI":"10.1152\/ajpheart.01348.2007","article-title":"Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia","volume":"295","author":"Dayal","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0040","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0008-6363(99)00162-5","article-title":"Biological significance of endogenous methylarginines that inhibit nitric oxide synthases","volume":"43","author":"Leiper","year":"1999","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.clinbiochem.2012.06.024_bb0045","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.ATV.20.6.1557","article-title":"Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst-(e)inemia or hypercholesterolemia","volume":"20","author":"Boger","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14\u201315","key":"10.1016\/j.clinbiochem.2012.06.024_bb0050","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.clinbiochem.2008.07.011","article-title":"Determination of protein-incorporated methylated arginine reference values in healthy subjects whole blood and evaluation of factors affecting protein methylation","volume":"41","author":"Zinellu","year":"2008","journal-title":"Clin Biochem"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.06.024_bb0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1373\/clinchem.2006.076711","article-title":"Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study)","volume":"53","author":"Meinitzer","year":"2007","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.06.024_bb0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0021-9150(01)00444-0","article-title":"Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke","volume":"158","author":"Yoo","year":"2001","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.clinbiochem.2012.06.024_bb0065","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0197-4580(03)00007-1","article-title":"Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease","volume":"24","author":"Selley","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00726-005-0191-z","article-title":"Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects","volume":"28","author":"Paroni","year":"2005","journal-title":"Amino Acids"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1365-2362.2003.01184.x","article-title":"Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease","volume":"33","author":"Jonasson","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0080","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.metabol.2004.09.015","article-title":"Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia","volume":"54","author":"Doshi","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2265.2006.02497.x","article-title":"No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk","volume":"64","author":"Spoelstra-de Man","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.atherosclerosis.2006.06.007","article-title":"Effects of combined supplementation with B vitamins and antioxidants on plasma levels of asymmetric dimethylarginine (ADMA) in subjects with elevated risk for cardiovascular disease","volume":"193","author":"Schmitt","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0095","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1210\/jc.2004-1087","article-title":"Homocyst(e)ine-lowering therapy does not affect plasma asymmetrical dimethylarginine concentrations in patients with peripheral artery disease","volume":"90","author":"Ziegler","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0100","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1161\/01.STR.0000131749.81508.18","article-title":"Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice","volume":"35","author":"Dayal","year":"2004","journal-title":"Stroke"},{"issue":"18","key":"10.1016\/j.clinbiochem.2012.06.024_bb0105","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia","volume":"98","author":"B\u00f6ger","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0110","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00005344-199904000-00020","article-title":"Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension","volume":"33","author":"Surdacki","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0115","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.287.11.1420","article-title":"Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor","volume":"287","author":"St\u00fchlinger","year":"2002","journal-title":"J Am Med Assoc"},{"issue":"10","key":"10.1016\/j.clinbiochem.2012.06.024_bb0120","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9149(01)02063-X","article-title":"Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus","volume":"88","author":"Abbasi","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(03)00338-3","article-title":"Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases","volume":"336","author":"Fleck","year":"2003","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.06.024_bb0130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2005.05.002","article-title":"Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease","volume":"184","author":"Wang","year":"2006","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.clinbiochem.2012.06.024_bb0135","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.metabol.2004.06.026","article-title":"Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine","volume":"53","author":"Eid","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0140","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2337\/diacare.24.2.362","article-title":"Homeostasis Model Assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes","volume":"24","author":"Katsuki","year":"2001","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.clinbiochem.2012.06.024_bb0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0150","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","article-title":"A more meaningful scoring system for determining the severity of coronary heart disease","volume":"51","author":"Gensini","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0155","doi-asserted-by":"crossref","first-page":"12503","DOI":"10.1073\/pnas.231428998","article-title":"Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction","volume":"98","author":"Weiss","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.clinbiochem.2012.06.024_bb0160","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1515\/CCLM.2011.121","article-title":"Carotid restenosis is associated with plasma ADMA concentrations in carotid endarterectomy patients","volume":"49","author":"Zinellu","year":"2011","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"10.1016\/j.clinbiochem.2012.06.024_bb0165","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/art.27392","article-title":"Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patient","volume":"62","author":"Perna","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2012.06.024_bb0170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cca.2010.09.026","article-title":"Asymmetric dimethylarginine as a risk marker for early-onset ischemic stroke in Indian population","volume":"412","author":"Mamatha","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.06.024_bb0175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-3083.2009.02261.x","article-title":"Association between asymmetric dimethylarginine and neopterin in patients with and without angiographic coronary artery disease","volume":"70","author":"Murr","year":"2009","journal-title":"Scand J Immunol"},{"issue":"17","key":"10.1016\/j.clinbiochem.2012.06.024_bb0180","doi-asserted-by":"crossref","first-page":"10205","DOI":"10.1016\/S0021-9258(18)81786-0","article-title":"Purification and properties of a new enzyme, NG, NGdimethylarginine dimethylaminohydrolase, from rat kidney","volume":"264","author":"Ogawa","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0185","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1161\/hc4601.098514","article-title":"Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine","volume":"104","author":"Stuhlinger","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0190","doi-asserted-by":"crossref","first-page":"13527","DOI":"10.1073\/pnas.212269799","article-title":"S-Nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase","volume":"99","author":"Leiper","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0195","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/90387","article-title":"Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase","volume":"8","author":"Murray-Rust","year":"2001","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0200","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.amjcard.2004.11.023","article-title":"Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment","volume":"95","author":"Bae","year":"2005","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.clinbiochem.2012.06.024_bb0205","first-page":"524","article-title":"NG, NG-dimethylarginine and NG, NG-dimethylarginine in renal insufficiency","volume":"439","author":"Al Banchaabouchi","year":"2000","journal-title":"Pflugers Arch"},{"issue":"4","key":"10.1016\/j.clinbiochem.2012.06.024_bb0210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5414\/CNP62295","article-title":"Low dialysance of asymmetric dimethylarginine (ADMA) - in vivo and in vitro evidence of significant protein binding","volume":"62","author":"Kielstein","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0215","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.atherosclerosis.2005.06.033","article-title":"Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population","volume":"185","author":"Wanby","year":"2006","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.clinbiochem.2012.06.024_bb0220","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1567-5688(03)00029-1","article-title":"Asymmetrical dimethylarginine (ADMA) and risk of acute coronary events. Does statin treatment influence plasma ADMA levels?","volume":"4","author":"Valkonen","year":"2003","journal-title":"Atheroscler Suppl"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.06.024_bb0225","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/01.HYP.0000231509.27406.42","article-title":"Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress","volume":"48","author":"Zhang","year":"2006","journal-title":"Hypertension"},{"issue":"Suppl. 48","key":"10.1016\/j.clinbiochem.2012.06.024_bb0230","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1042\/CS103S241S","article-title":"Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure","volume":"103","author":"Ohnishi","year":"2002","journal-title":"Clin Sci (Lond)"},{"issue":"26","key":"10.1016\/j.clinbiochem.2012.06.024_bb0235","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/S0024-3205(98)00225-2","article-title":"Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure","volume":"62","author":"Usui","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.clinbiochem.2012.06.024_bb0240","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/clc.4960261006","article-title":"Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease","volume":"26","author":"Lu","year":"2003","journal-title":"Clin Cardiol"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012003281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012003281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:39:08Z","timestamp":1757864348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912012003281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":48,"journal-issue":{"issue":"16-17","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0009912012003281"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.06.024","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}